These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 9156265

  • 1. Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease.
    Salat C, Holler E, Kolb HJ, Pihusch R, Reinhardt B, Hiller E.
    Bone Marrow Transplant; 1997 May; 19(9):909-14. PubMed ID: 9156265
    [Abstract] [Full Text] [Related]

  • 2. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
    Zeigler ZR, Rosenfeld CS, Andrews DF, Nemunaitis J, Raymond JM, Shadduck RK, Kramer RE, Gryn JF, Rintels PB, Besa EC, George JN.
    Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
    [Abstract] [Full Text] [Related]

  • 3. The levels of soluble P-selectin, von Willebrand factor and thrombomodulin in patients with neurological complications after allogeneic bone marrow transplantation.
    Takatsuka H, Takemoto Y, Okamoto T, Fujimori Y, Suehiro A, Kakishita E, Kanamaru A.
    Bone Marrow Transplant; 1998 Apr; 21(8):809-13. PubMed ID: 9603405
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. von Willebrand factor as a marker of endothelial cell activation following BMT.
    Collins PW, Gutteridge CN, O'Driscoll A, Blair S, Jones L, Aitchison R, Kelsey SM, Chopra R, Goldstone A, Newland AC.
    Bone Marrow Transplant; 1992 Dec; 10(6):499-506. PubMed ID: 1490199
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Can von Willebrand factor, platelet-endothelial cell adhesion molecule-1 and thrombomodulin be used as alternative markers of endothelial cell injury in human glomerulonephritis?
    Niemir ZI, Kubiak A, Olejniczak P, Nowak A, Czekalski S.
    Rocz Akad Med Bialymst; 2004 Dec; 49():213-8. PubMed ID: 15631346
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M, Iravani M, Babaee GR, Ghavamzadeh A.
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells.
    Ji S, Chen H, Wang H, Ma J, Pan S, Xue M, Zhu L, Liu J, Xiao M, Zhou L.
    Chin Med J (Engl); 2001 Feb; 114(2):191-5. PubMed ID: 11780205
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relationship between CsA trough blood concentration and severity of acute graft-versus-host disease after paediatric stem cell transplantation from matched-sibling or unrelated donors.
    Martin P, Bleyzac N, Souillet G, Galambrun C, Bertrand Y, Maire PH, Jelliffe RW, Aulagner G.
    Bone Marrow Transplant; 2003 Oct; 32(8):777-84. PubMed ID: 14520421
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantation.
    Testa S, Manna A, Porcellini A, Maffi F, Morstabilini G, Denti N, Macchi S, Rosti G, Porcellini G, Cassi D, Ferrari L.
    Bone Marrow Transplant; 1996 Aug; 18(2):383-8. PubMed ID: 8864450
    [Abstract] [Full Text] [Related]

  • 18. [Relationship between soluble Fas ligand levels and complications after allogeneic bone marrow transplantation].
    Huang X, Wan J, Guo N, Lu D.
    Zhonghua Xue Ye Xue Za Zhi; 2001 Feb; 22(2):83-5. PubMed ID: 11877055
    [Abstract] [Full Text] [Related]

  • 19. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY, Freestone B, Patel J, Lim HS, Hughes E, Blann AD, Lip GY.
    Am J Cardiol; 2006 Mar 01; 97(5):671-5. PubMed ID: 16490435
    [Abstract] [Full Text] [Related]

  • 20. Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.
    Remberger M, Ringdén O.
    Transplantation; 1995 Dec 15; 60(11):1293-9. PubMed ID: 8525524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.